Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Apr 15, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how well oxygen therapy works during sedation in children. Specifically, researchers want to find out if giving oxygen through regular nasal prongs or a high flow nasal cannula (a device that delivers oxygen through the nose) is safe and effective for pediatric patients who need moderate to deep sedation for medical procedures. The goal is to ensure that children receive the best care possible while they are sedated.

To participate in this study, children must be under 18 years old and require sedation. However, there are certain conditions that would prevent a child from joining, such as having serious breathing problems or recent nosebleeds. If a child is eligible and chooses to participate, they can expect to receive either regular oxygen or high flow oxygen during their sedation process, and their safety and comfort will be closely monitored throughout the trial. This study is currently looking for participants, so it’s a great opportunity to help improve pediatric sedation practices.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children under the age of 18 who undergo moderate-deep sedation
• Exclusion Criteria:
• • Respiratory failure patients
• • Increased intracranial pressure
• • Recent massive nasal bleeding
• • History of airway surgery
• • Complete nasal obstruction
• • Pulmonary hypertension
• • Skull base fracture